On July 18-19, 2017, the NIH Office of Science Policy held a workshop on the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The goals of the workshop were to examine the current biosafety oversight framework, and discuss the future direction of biosafety oversight in light of the emergence of new technologies in the life sciences and the evolution in our understanding of risk and safety.
Questions about the workshop may be sent to NIHGuidelines@od.nih.gov.
Asilomar ’75: The Beginning of the Future
A retrospective video from some of the participants of the landmark “International Congress on Recombinant DNA Molecules” (aka Asilomar Conference) regarding the legacy of that historical event.
Session I – David Baltimore, Ph.D.
Session II – Jessica Tucker, Ph.D.
Session II – Stephen J. Libby, Ph.D.
Session II – Hans-Peter Kiem, M.D., Ph.D.
Session III – Deborah E. Wilson, RADM, DrPH, CBSP
Session III – Samuel Edwin, Ph.D.
Session III – Thomas Nerad, MPH, Ph.D.
Session IV – Zach Adelman, Ph.D.
Attendees may view the meeting remotely by visiting www.videocast.nih.gov, or clicking on the links below:
Day 1: https://videocast.nih.gov/summary.asp?live=24762&bhcp=1
Day 2: https://videocast.nih.gov/summary.asp?live=24766&bhcp=1